Eli Lilly and Company (NYSE:LLY) is one of billionaire Cliff Asness’ top 10 healthcare stock picks. On June 25, Eli Lilly and ...

The sell-off in this stock has created a great buying opportunity.

Merck & Co., Inc. (NYSE:MRK) is one of billionaire Cliff Asness’ top 10 healthcare stock picks. On June 25, Merck & Co., Inc.

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) is one of billionaire Cliff Asness’ top 10 healthcare stock picks. On June 8, Neurocrine Biosciences, Inc. (NASDAQ:NBIX) presented new data at the Psych ...

Listen Now: Listen and subscribe to Morningstar’s The Long View from your mobile device: Apple Podcasts | Spotify Today on the podcast we welcome back Cliff Asness. Cliff is the founder, managing ...

AQR Capital Management’s Cliff Asness says the quant firm is actively deploying artificial intelligence — including in the core parts of the investing process that used to be the co-founder’s domain.

We recently published a list of Billionaire Cliff Asness’ 10 Stock Picks with Huge Upside Potential. In this article, we are going to take a look at where Neurocrine Biosciences, Inc. (NASDAQ:NBIX) ...

In this article, we will highlight Billionaire Cliff Asness’ Top 10 Healthcare Stock Picks. Cliff Asness is a billionaire investor and the co-founder and chief investment officer of AQR Capital ...

AQR Capital Management took advantage of a volatile first half of 2025, with a duo of hedge funds doubling the S&P 500's return. The Apex strategy from Cliff Asness' firm, which combines stocks, macro ...

Hedge fund executive Cliff Asness says artificial intelligence is becoming “annoyingly better” at doing parts of his job. AI deployed by his firm AQR Capital Management, where I worked for a decade, ...

"I feel fear… because they're somewhat vindictive people. I don't care who you are, having this set of people mad at you is not comfortable." That's today's guest, Cliff Asness, talking about ...

After a rough stretch, investment firm AQR is on a 5-year hot streak thanks to a new AI infused investing strategy and strong tax-friendly returns, beloved by financial advisors. Last year was a ...